Free Trial
OTCMKTS:IMUCD

ImmunoCellular Therapeutics (IMUCD) Stock Price, News & Analysis

$0.10 +0.03 (+51.42%)
As of 06/30/2025

About ImmunoCellular Therapeutics Stock (OTCMKTS:IMUCD)

Key Stats

Today's Range
$0.10
$0.10
50-Day Range
$0.06
$0.14
52-Week Range
$0.16
$0.51
Volume
220 shs
Average Volume
6,605 shs
Market Capitalization
$425.70 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMUCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoCellular Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

IMUCD Stock News Headlines

RVVTF - Revive Therapeutics Ltd.
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

IMUCD Stock Analysis - Frequently Asked Questions

ImmunoCellular Therapeutics' stock was trading at $0.1688 at the beginning of 2025. Since then, IMUCD shares have decreased by 39.8% and is now trading at $0.1016.
View the best growth stocks for 2025 here
.

Shares of IMUCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:IMUCD
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$425.70 thousand
Optionable
Not Optionable
Beta
1.63
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:IMUCD) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners